pharmml.org
First paper on PharmML... - pharmML
http://www.pharmml.org/news/firstpaperonpharmml
First paper on PharmML. Posted May 13, 2015, 8:07 AM. By Maciek J Swat [ updated Jun 8, 2015, 4:01 AM. Has been accepted for publication in CPT:PSP! More details and URL to follow soon. Follow us on Twitter. Last modified on 13 January 2016.
occams.eu
Occams
http://www.occams.eu/justinw.html
Justin was born in Bellville, South Africa in 1974. After completing his PhD thesis on the PK of rifampicin, isoniazid, and pyrazinamide at the University of Cape Town. In 2004 (following a BSc (Hons) and an MSc in the pharmacoeconomics of malaria), Justin moved to Sweden to join Uppsala University. In Basel in 2006, where he provided pharmacometric support for projects in respiratory disease and oncology; at the same time, he played a central role in launching the DDMoRe. Has been a co-developer of Xpose.
simulx.webpopix.org
User Guide - Simulx
http://simulx.webpopix.org/userguide
User Guide - Simulx. Simulx & Shiny. Simulx User Guide – version 3.1. New versions of the User Guide published with bookdown. Are also available: HTML. Download the R scripts, Mlxtran and pharmML codes used for this user guide. Calculation of functions of time. Function of time with analytical expression. Function of time solution of a system of ordinary differential equations (ODEs). Function of time solution of a system of delay differential equations (DDEs). Model with regression variables. Creating o...
simulx.webpopix.org
Imprint - Simulx
http://simulx.webpopix.org/imprint
Simulx & Shiny. Simulx is developed by the Inria Xpop team for the DDMoRe project. Simulx is governed by the CeCILL-B license. Simulx requires the Lixoft simulation engine.
simulx.webpopix.org
Notes - Simulx
http://simulx.webpopix.org/notes
Simulx & Shiny. Simulx is developed by the Inria Xpop team for the DDMoRe project. Simulx is governed by the CeCILL-B license. Simulx requires the Lixoft simulation engine.
pharmml.org
Sitemap - pharmML
http://www.pharmml.org/system/app/pages/sitemap/hierarchy
Follow us on Twitter. The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant agreement n 115156, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. The DDMoRe project is also financially supported by contributions from Academic and SME partners. Last modified on 13 January 2016.
pharmml.org
Detailed PK macros document available - pharmML
http://www.pharmml.org/news/detailedpkmacrosdocumentavailable
Detailed PK macros document available. Posted Feb 18, 2015, 2:08 AM. By Maciek J Swat [ updated Jun 8, 2015, 4:01 AM. Detailed document describing the PK macros introduced in PharmML 0.6 is available now,go to Documentation. It extends the specification and comes with more examples. For example, all NONMEM PREDPP predefined models, ADVAN1-4 and 10-12 with basic parameterisation TRANS1, are covered. Moreover four complex administration models are implemented. Follow us on Twitter.
pharmml.org
Contact - pharmML
http://www.pharmml.org/links
We are looking forward to your feedback via. Email: (pharmml DOT contact AT gmail DOT com) or. Follow us on Twitter. Last modified on 13 January 2016.
pharmml.org
News - pharmML
http://www.pharmml.org/news
PharmML 0.9 is out! Posted Jul 22, 2016, 5:54 AM. By Maciek J Swat. New in this version:. Mixtures of structural models (wsmm, bsmm). New DE notation - encodable are ODEs, DDEs and PDEs with boundary and initial conditions. Autocorrelation models of residual errors. BoxCox2 and user-defined transformations. Updated covariates, occasions and design spaces handling in TD. Exclusion and inclusion criteria for covariates. Categorical covariates building (clustering). Other minor extensions and changes. ProbO...
pharmml.org
Slide show - pharmML
http://www.pharmml.org/documentation2/slide-show
The following slides show few figures from the PharmML specification 0.6 exemplifying some aspects of the new release. Follow us on Twitter. Last modified on 13 January 2016.
SOCIAL ENGAGEMENT